Detalles de la búsqueda
1.
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
Br J Cancer
; 130(8): 1249-1260, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361045
2.
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging.
Int J Mol Sci
; 24(3)2023 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769215
3.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252375
4.
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Lancet Oncol
; 19(1): 40-50, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29233559
5.
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
J Ovarian Res
; 16(1): 150, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525239
6.
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma.
Hum Pathol
; 141: 158-168, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37742945
7.
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.
Clin Cancer Res
; 29(22): 4606-4612, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725572
8.
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.
Neoplasia
; 44: 100934, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37703626
9.
Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.
Cancers (Basel)
; 13(5)2021 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33802395
10.
Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.
Cancers (Basel)
; 13(7)2021 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33806030
11.
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status.
Clin Epigenetics
; 13(1): 184, 2021 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34602069
12.
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer.
Clin Cancer Res
; 27(9): 2584-2591, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593886
13.
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
Eur J Cancer
; 148: 159-170, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743484
14.
MALDI-Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods.
Proteomics Clin Appl
; 13(1): e1700181, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30471200
15.
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial.
Clin Cancer Res
; 25(13): 3986-3995, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30979740
16.
Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node-positive study.
Eur J Cancer
; 114: 76-88, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31075727
17.
NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto.
J Clin Oncol
; 37(25): 2226-2234, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31082269
18.
High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism.
Oncotarget
; 8(61): 102912-102922, 2017 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29262533
19.
Transposable elements--is there a link between evolution and cancer?
Med Hypotheses
; 66(3): 580-91, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16239072
20.
Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas.
Cancer Res
; 76(4): 796-804, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26685161